Multiple Sclerosis International

Stride-Time Variability and Fall Risk in Persons with Multiple Sclerosis

The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis

The Communication of Multiple Sclerosis Diagnosis: The Patients’ Perspective

Comparing Three Dual-Task Methods and the Relationship to Physical and Cognitive Impairment in People with Multiple Sclerosis and Controls

Adipsin Is Associated with Multiple Sclerosis: A Follow-Up Study of Adipokines

Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities

Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study

Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study

EDSS Change Relates to Physical HRQoL While Relapse Occurrence Relates to Overall HRQoL in Patients with Multiple Sclerosis Receiving Subcutaneous Interferon β-1a

Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis

Development of Activity-Related Muscle Fatigue during Robot-Mediated Upper Limb Rehabilitation Training in Persons with Multiple Sclerosis: A Pilot Trial

Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials

The Lived Experience of Multiple Sclerosis Relapse: How Adults with Multiple Sclerosis Processed Their Relapse Experience and Evaluated Their Need for Postrelapse Care

Does Self-Efficacy Affect Cognitive Performance in Persons with Clinically Isolated Syndrome and Early Relapsing Remitting Multiple Sclerosis?

Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta-Analysis

Multiple Sclerosis International

Table of Contents

Table of Contents: 2015

Stride-Time Variability and Fall Risk in Persons with Multiple Sclerosis

The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis

The Communication of Multiple Sclerosis Diagnosis: The Patients’ Perspective

Comparing Three Dual-Task Methods and the Relationship to Physical and Cognitive Impairment in People with Multiple Sclerosis and Controls

Adipsin Is Associated with Multiple Sclerosis: A Follow-Up Study of Adipokines

Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities

Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study

Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study

EDSS Change Relates to Physical HRQoL While Relapse Occurrence Relates to Overall HRQoL in Patients with Multiple Sclerosis Receiving Subcutaneous Interferon β-1a

Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis

Development of Activity-Related Muscle Fatigue during Robot-Mediated Upper Limb Rehabilitation Training in Persons with Multiple Sclerosis: A Pilot Trial

Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials

The Lived Experience of Multiple Sclerosis Relapse: How Adults with Multiple Sclerosis Processed Their Relapse Experience and Evaluated Their Need for Postrelapse Care

Does Self-Efficacy Affect Cognitive Performance in Persons with Clinically Isolated Syndrome and Early Relapsing Remitting Multiple Sclerosis?

Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta-Analysis